Pfizer to buy obesity startup Metsera for $4.9 billion; shares jump on Wall Street - Details here
Published on: Sept. 22, 2025, 8:35 p.m. | Source: Livemint
Pfizer Inc. is set to pay $4.9 billion for the obesity startup Metsera Inc., as the pharma company plans to catch up with the rival drugmakers. Shares of both companies jumped on Wall Street at the opening bell after the corporate update.
